NCT03421366View on ClinicalTrials.gov

Modified Release Posaconazole in Patients With Cystic Fibrosis

UnknownOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

February 5, 2021

Study Completion Date

February 5, 2021

Conditions
Cystic Fibrosis
Interventions
DRUG

Posaconazole

A triazole antifungal drug that is used to treat invasive infections by Candida species and Aspergillus species in severely immunocompromised patients

Trial Locations (1)

3004

RECRUITING

Alfred Hospital, Melbourne

Sponsors

Lead Sponsor

Bayside Health
All Listed Sponsors
lead

Bayside Health

OTHER_GOV